Skip to content

Effect of Viola odorata syrup on aleviating the manifestations of COVID-19 (Corona) infection: A double-blind placebo controlled trial

Effect of Viola odorata syrup on aleviating the manifestations of COVID-19 (Corona) infection: A double-blind placebo controlled trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190409043215N2
Enrollment
100
Registered
2021-02-14
Start date
2020-12-20
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. Coronavirus infection, unspecified

Interventions

Intervention 1: Intervention group: recipient of violet syrup, in the amount of 10 ml three times a day for 5 days. Violet syrup contains aqueous extract of violet flowers and leaves and sugar, which

Sponsors

Tehran University of Medical Sciences
Lead Sponsor
Barij Essence Pharmaceutical Company
Collaborator

Eligibility

Sex/Gender
All
Age
15 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients referred to Al-Zahra Hospital (Isfahan) who diagnosed COVID-19 based on clinical symptoms and blood oxygen saturation along with CT scan of the lung with the approval of a radiologist and / or positive PCR for them. Blood oxygen saturation greater than or equal to 90%. The age range of patients is 15 to 75 years Both sexes Satisfaction to participate in the study

Exclusion criteria

Exclusion criteria: Diabetic patients Patients with allergies to herbal products Severe forms of covid-19 disease (respiratory rate> 24 or percnt of blood saturated oxygenation <90%) Patients with diarrhea

Design outcomes

Primary

MeasureTime frame
Severity of shortness of breath. Timepoint: Once a day for 6 days. Method of measurement: Questionary.;Intensity of cough. Timepoint: Once a day for 6 days. Method of measurement: Questionnaire.;Blood oxygen. Timepoint: Once a day for 6 days. Method of measurement: Pulse oximeter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMeysam Shirzad

Tehran University of Medical Sciences

shirzadmd@gmail.com+98 21 8897 4535

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026